@article{d3e79855be374333a8eddc8010e922fa,
title = "Re-induction with intravenous Ustekinumab after secondary loss of response is a valid optimization strategy in Crohn's disease",
keywords = "Crohn's disease, treatment failure, Ustekinumab, MAINTENANCE THERAPY, MODERATE",
author = "{Ten Bokkel Huinink}, Sebastiaan and Vince Biemans and Marjolijn Duijvestein and Marieke Pierik and Frank Hoentjen and West, {Rachel L} and {van der Woude}, {Christien J} and {de Vries}, {Annemarie C}",
note = "Copyright {\textcopyright} 2021 Wolters Kluwer Health, Inc. All rights reserved.",
year = "2021",
month = dec,
day = "1",
doi = "10.1097/MEG.0000000000002256",
language = "English",
volume = "33",
pages = "e783--e788",
journal = "European Journal of Gastroenterology & Hepatology",
issn = "0954-691X",
publisher = "LIPPINCOTT WILLIAMS & WILKINS",
number = "1S Suppl 1",
}